Robins Kaplan Adds Wilson Sonsini Drug Patent Atty In NY

Law360, New York (July 5, 2012, 2:48 PM EDT) -- Robins Kaplan Miller & Ciresi LLP has boosted its life sciences and Hatch-Waxman intellectual property group in New York with the addition of a former Wilson Sonsini Goodrich & Rosati PC attorney who specializes in generic pharmaceutical patent cases.

Jeffrey Hovden, who is joining the firm as a partner, focuses on such cases under the Hatch-Waxman Act and within the biotechnology industry with clients including generics makers and name-brand drugmakers. The firm announced the addition of Hovden on June 25.

Ronald J. Schutz, the chairman of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.